Target intelligence / Profile preview

Retinoic acid receptor responder 2 pseudogene 9 (RARRES2P9)

Target
RARRES2P9
Molecular classification
Pseudogene
01

Overview

Retinoic acid receptor responder 2 pseudogene 9 (RARRES2P9) is a pseudogene in the human genome[1][3][7][11]. By definition, a pseudogene is a DNA segment that resembles a functional gene but is generally nonfunctional due to mutations or lack of essential regulatory elements[4]. RARRES2P9 does not code for a functional protein, and there is no evidence that it serves as a therapeutic target, receptor, enzyme, or other druggable molecule[1][3][7][11]. Pseudogenes can sometimes participate in gene regulation at the RNA level (such as acting as a source of regulatory RNAs), but there is no specific literature supporting a well-defined biological or disease role for RARRES2P9[4][2]. This entity is often included in gene databases for completeness, but it is not used as a therapeutic or diagnostic target, and no drugs are known to interact with it[3][7]. It is not associated with a protein, signal pathway, or named mechanism of action. The term “pseudogene” in its name clearly indicates that it is a nonfunctional remnant of a gene, likely arising through duplication or retrotransposition processes[4]. Rarely, pseudogenes can impact biology by serving as decoys for miRNAs or generating non-coding RNAs, but these functions are not established for RARRES2P9[2][4]. Because it is not a functional gene product, listing RARRES2P9 as a therapeutic or research target would be incorrect. Note: - The entry is included as a genomic annotation but does not represent a canonical therapeutic target. - Databases such as NCBI Gene and GeneCards clearly label RARRES2P9 as a pseudogene without attributed function or disease roles[1][3][7][11].

Other names
Retinoic acid receptor responder (tazarotene induced) 2 pseudogene 9
02

Biological functions

Other (pseudogene; may have regulatory functions, not a protein product)

Beyond the preview

Go deeper on Retinoic acid receptor responder 2 pseudogene 9 (RARRES2P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoic acid receptor responder 2 pseudogene 9 (RARRES2P9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call